Owkin
Venkat Sethuraman is a seasoned professional in the field of biometrics and data sciences, currently serving as the Senior Vice President at Bristol-Myers Squibb. With a strong background in leadership roles, Venkat also holds positions as a Board Observer at Owkin and as a Director on the Board of the Association for Women in Science. Previously, Venkat was a Principal/Partner at ZS and served as Vice President and Executive Director of Global Biometric Sciences at Bristol-Myers Squibb. Venkat earned a PhD in Statistics from Temple University and has completed studies at The Wharton School.
This person is not in the org chart
This person is not in any teams
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.